DEVELOPMENT OF IGA AND IGG2 SUBCLASS DEFICIENCY AFTER SULFASALAZINE THERAPY

被引:25
作者
LEICKLY, FE
BUCKLEY, RH
机构
关键词
D O I
10.1016/S0022-3476(86)80907-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:481 / 482
页数:2
相关论文
共 10 条
[1]   HLA ANTIGENS IN PRIMARY IMMUNODEFICIENCY DISEASES [J].
BUCKLEY, RH ;
MACQUEEN, JM ;
WARD, FE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1977, 7 (03) :305-310
[2]   SULPHASALAZINE INDUCED SELECTIVE IGA DEFICIENCY IN RHEUMATOID-ARTHRITIS [J].
DELAMERE, JP ;
FARR, M ;
GRINDULIS, KA .
BRITISH MEDICAL JOURNAL, 1983, 286 (6377) :1547-1548
[3]  
HEIKKILA M, 1984, TISSUE ANTIGENS, V23, P280
[4]  
LAWTON AP, 1974, IMMUNOGLOBULIN A SYS, P373
[5]   SULFASALAZINE - PHARMACOLOGY, CLINICAL USE, TOXICITY, AND RELATED NEW DRUG DEVELOPMENT [J].
PEPPERCORN, MA .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) :377-386
[6]  
SARILAHTI E, 1983, BMJ-BRIT MED J, V287, P759
[7]  
SARILAHTI E, 1979, ACTA PAEDIATR SCAND, V68, P513
[8]  
SEAGER J, 1975, LANCET, V2, P632
[9]  
STANWORTH DR, 1977, LANCET, V1, P1001
[10]  
Ugazio A G, 1983, Birth Defects Orig Artic Ser, V19, P169